Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron

gan Strauss, William E, Auerbach, Michael
Cyhoeddwyd yn Patient Relat Outcome Meas (2018)

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

gan Glaspy, John A., Wolf, Myles, Strauss, William E.
Cyhoeddwyd yn Adv Ther (2021)

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia

gan Strauss, William E., Dahl, Naomi V., Li, Zhu, Lau, Gloria, Allen, Lee F.
Cyhoeddwyd yn BMC Hematol (2016)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

gan Vadhan-Raj, Saroj, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Strauss, William E
Cyhoeddwyd yn J Blood Med (2017)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial

gan Macdougall, Iain C., Strauss, William E., Dahl, Naomi V., Bernard, Kristine, Li, Zhu
Cyhoeddwyd yn Clin Nephrol (2019)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

gan Dahl, Naomi V, Kaper, Robert F, Strauss, William E, Corvino, Frank A, Zivkovic, Marko
Cyhoeddwyd yn Clinicoecon Outcomes Res (2017)

A Randomized Comparison of Ferumoxytol and Iron Sucrose for Treating Iron Deficiency Anemia in Patients with CKD

gan Macdougall, Iain C., Strauss, William E., McLaughlin, Justin, Li, Zhu, Dellanna, Frank, Hertel, Joachim
Cyhoeddwyd 2014

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale...

gan Macdougall, Iain C., Dahl, Naomi V., Bernard, Kristine, Li, Zhu, Batyky, Alka, Strauss, William E.
Cyhoeddwyd yn BMC Nephrol (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background...

gan Macdougall, Iain C., Dahl, Naomi V., Bernard, Kristine, Li, Zhu, Batycky, Alka, Strauss, William E.
Cyhoeddwyd yn BMC Nephrol (2018)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind stud...

gan Adkinson, N Franklin, Strauss, William E, Bernard, Kristine, Kaper, Robert F, Macdougall, Iain C, Krop, Julie S
Cyhoeddwyd yn J Blood Med (2017)

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open...

gan Vadhan-Raj, Saroj, Ford, David C, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Allen, Lee F, Strauss, William E
Cyhoeddwyd yn Am J Hematol (2016)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

gan Ford, David C, Dahl, Naomi V, Strauss, William E, Barish, Charles F, Hetzel, David J, Bernard, Kristine, Li, Zhu, Allen, Lee F
Cyhoeddwyd yn Clin Exp Gastroenterol (2016)

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial

gan Adkinson, N. Franklin, Strauss, William E., Macdougall, Iain C., Bernard, Kristine E., Auerbach, Michael, Kaper, Robert F., Chertow, Glenn M., Krop, Julie S.
Cyhoeddwyd yn Am J Hematol (2018)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review

gan Glaspy, John A, Lim-Watson, Michelle Z, Libre, Michael A, Karkare, Swagata S, Hadker, Nandini, Bajic-Lucas, Aleksandra, Strauss, William E, Dahl, Naomi V
Cyhoeddwyd yn Ther Clin Risk Manag (2020)